Levixa Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Levofloxacin hemihydrate

Indications/Uses

Mild, moderate & severe infections eg, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, complicated UTI including pyelonephritis, chronic bacterial prostatitis, skin & soft tissue infections.

Click to view Levixa detailed prescribing information

Dosage/Direction for Use

Acute bacterial exacerbations of chronic bronchitis 500 mg for 7 days. Nosocomial pneumonia 750 mg for 7-14 days. Community-acquired pneumonia 500 mg for 7-14 days. Acute bacterial sinusitis 500 mg for 10-14 days. Uncomplicated skin & skin structure infections 500 mg for 7-10 days. Complicated skin & skin structure infections 750 mg for 7-14 days. Chronic bacterial prostatitis 500 mg for 28 days. Uncomplicated UTI 500 mg for 3 days. Complicated UTI 750 mg for 5 days. Acute pyelonephritis 750 mg for 5 days.

Click to view Levixa detailed prescribing information

Overdosage

View Levixa overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity to levofloxacin & other quinolones. Epilepsy. Patients w/ history of tendon disorders associated w/ fluoroquinolone administration. Pregnancy & lactation. Childn or adolescents <18 yr.

Click to view Levixa detailed prescribing information

Special Precautions

Patients prone to seizures eg, w/ preexisting CNS lesions; those treated w/ fenbufen or NSAIDs, medicines which lower the cerebral seizure threshold eg, theophylline. May give false -ve results in bacteriological diagnosis of TB. Photosensitisation. May alter ability to drive or operate machinery.

Click to view Levixa detailed prescribing information

Adverse Reactions

Tendinopathy & tendon rupture; hypersensitivity reactions; severe hepatotoxicity; convulsions & toxic psychoses, ICP & CNS stimulation.

Click to view Levixa detailed prescribing information

Drug Interactions

May increase risk of seizures w/ antacids containing Mg or Al, sucralfate, metal cations eg, Fe. Blood glucose disturbances w/ oral hypoglycemic agent (eg, glyburide) or insulin.

Click to view Levixa detailed prescribing information

Storage

View Levixa storage conditions for details to ensure optimal shelf-life.

Description

View Levixa description for details of the chemical structure and excipients (inactive components).

Action

View Levixa mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Quinolones

ATC Classification

J01MA12 - levofloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.

Regulatory Classification

Presentation/Packing

Form

Levixa FC tab 500 mg

Packing/Price

100's;30's

Levixa

levofloxacin

Manufacturer:

Akriti Pharmaceuticals

Distributor:

EuroAsia